BridgeMD
New treatment option for Neonatal Respiratory Failure
Official title Flow and Grow - The Ideal Time to Wean CPAP Off In Extremely Low Birth Weight Infants
ClinicalTrials.gov ID: NCT06123143
What this study is testing
- What it's testing
- Preterm neonates born at less than 30 weeks' gestation are commonly maintained on invasive or non-invasive respiratory support to facilitate gas exchange. While non-invasive respiratory support (NIS) can be gradually reduced over time as the infant grows, most weaning strategies often lead to weaning failure.
- Time commitment: about 30 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 30
You may be able to join if
- All infants admitted to the NICU at Jacobs, Rancho Springs, Scripps La Jolla, Rady Children's Hospital, or Palomar born at \< 30 weeks CGA
- Informed parental consent obtained
You likely can't join if
- Declined or unable to give informed consent
- Infants with known congenital anomalies or complications that require long term support (pulmonary hypoplasia, airway defects, genetic syndromes...
- Intubated for over 4 weeks of life (28 days)
The study team makes the final eligibility decision.
Where it's taking place
- Escondido, California, United States
- La Jolla, California, United States
- Murrieta, California, United States
- San Diego, California, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 30 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, up to 30 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Escondido, California, United States; La Jolla, California, United States; Murrieta, California, United States; San Diego, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.